PT676413E - Proteina de ligacao a interferoes alfa/beta, sua preparacao e utilizacao - Google Patents

Proteina de ligacao a interferoes alfa/beta, sua preparacao e utilizacao

Info

Publication number
PT676413E
PT676413E PT95101560T PT95101560T PT676413E PT 676413 E PT676413 E PT 676413E PT 95101560 T PT95101560 T PT 95101560T PT 95101560 T PT95101560 T PT 95101560T PT 676413 E PT676413 E PT 676413E
Authority
PT
Portugal
Prior art keywords
alpha
preparation
beta
interferon
proteins
Prior art date
Application number
PT95101560T
Other languages
English (en)
Inventor
Daniela Novick
Menachem Rubinstein
Cohen Batya
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of PT676413E publication Critical patent/PT676413E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT95101560T 1994-02-07 1995-02-06 Proteina de ligacao a interferoes alfa/beta, sua preparacao e utilizacao PT676413E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL108584A IL108584A (en) 1994-02-07 1994-02-07 Cloning of the interferon-binding protein ALPHA / BETA

Publications (1)

Publication Number Publication Date
PT676413E true PT676413E (pt) 2005-05-31

Family

ID=11065792

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95101560T PT676413E (pt) 1994-02-07 1995-02-06 Proteina de ligacao a interferoes alfa/beta, sua preparacao e utilizacao

Country Status (17)

Country Link
EP (1) EP0676413B9 (pt)
JP (2) JP3670045B2 (pt)
KR (1) KR100382628B1 (pt)
CN (1) CN1286976C (pt)
AT (1) ATE286509T1 (pt)
AU (1) AU688430B2 (pt)
CA (1) CA2141747C (pt)
DE (1) DE69533905T2 (pt)
DK (1) DK0676413T3 (pt)
ES (1) ES2236696T3 (pt)
FI (1) FI118084B (pt)
IL (1) IL108584A (pt)
NO (1) NO318912B1 (pt)
PT (1) PT676413E (pt)
RU (4) RU2362781C2 (pt)
UA (1) UA46694C2 (pt)
ZA (1) ZA95968B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118096A0 (en) * 1996-05-01 1996-09-12 Yeda Res & Dev Antibodies against interferon alpha/beta receptor
US7087726B2 (en) * 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
CN1405181A (zh) * 2001-08-10 2003-03-26 中国人民解放军军事医学科学院生物工程研究所 血清白蛋白与干扰素的融合蛋白
CA2612378A1 (en) * 2005-06-22 2007-01-04 Genentech, Inc. Methods and compositions for targeting ifnar2
JP5104622B2 (ja) * 2008-07-29 2012-12-19 Jnc株式会社 磁性粒子を用いた測定対象物質の濃度測定法
AU2013211059B8 (en) * 2012-01-20 2017-12-21 Centre Hospitalier Regional Universitaire De Montpellier Targeted mutant alpha-helical bundle cytokines
TWI776808B (zh) 2016-04-29 2022-09-11 美商輝瑞大藥廠 干擾素β抗體及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653445B1 (fr) * 1989-10-20 1994-07-29 Centre Nat Rech Scient Fragment d'adnc codant pour le gene du recepteur de l'interferon alpha et procede de preparation d'une proteine correspondante.
ATE181961T1 (de) * 1991-04-17 1999-07-15 Medisup Int Nv Neue wasserlösliche polypeptide mit hoher affinität für alpha- und beta- interferone
IL106591A (en) * 1992-09-03 2008-03-20 Yeda Res & Dev Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
NO950420D0 (no) 1995-02-06
KR950032620A (ko) 1995-12-22
EP0676413A3 (en) 1996-04-03
ATE286509T1 (de) 2005-01-15
EP0676413A2 (en) 1995-10-11
AU1141695A (en) 1995-08-17
FI118084B (fi) 2007-06-29
DK0676413T3 (da) 2005-05-09
JP3670045B2 (ja) 2005-07-13
CN1286976C (zh) 2006-11-29
RU2232811C2 (ru) 2004-07-20
CA2141747C (en) 2012-05-01
RU2004106775A (ru) 2005-08-10
RU2336279C2 (ru) 2008-10-20
FI950516A (fi) 1995-08-08
EP0676413B1 (en) 2005-01-05
IL108584A0 (en) 1994-05-30
CA2141747A1 (en) 1995-08-08
JPH07298886A (ja) 1995-11-14
IL108584A (en) 2008-03-20
RU2362781C2 (ru) 2009-07-27
ZA95968B (en) 1995-10-10
NO318912B1 (no) 2005-05-23
CN1109505A (zh) 1995-10-04
FI950516A0 (fi) 1995-02-06
JP2005200422A (ja) 2005-07-28
DE69533905T2 (de) 2005-12-29
RU2363705C2 (ru) 2009-08-10
AU688430B2 (en) 1998-03-12
DE69533905D1 (de) 2005-02-10
EP0676413B9 (en) 2005-05-18
UA46694C2 (uk) 2002-06-17
NO950420L (no) 1995-08-08
KR100382628B1 (ko) 2004-02-25
RU2004106773A (ru) 2005-08-10
RU2004106774A (ru) 2005-08-10
ES2236696T3 (es) 2005-07-16

Similar Documents

Publication Publication Date Title
IL96907A0 (en) Proteins produced by human lymphocytes,a dna sequence coding for said proteins and their pharmaceutical and biological application
DE3587864D1 (de) Rekombinant-dns-moleküle.
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
ES8602121A1 (es) Procedimiento para producir un vehiculo de expresion para la formacion de uroquinasa humana
DE69514342D1 (de) Modifizierte polypeptide mit erhoehter biologischer aktivitaet
DK216589D0 (da) Dna sekvenser, rekombinante dna molekyler samt fremgangsmaader til fresmtilling af oploeselige t4-proteiner
DE68903576D1 (de) Signalpeptide, die in hefe wirksam sind und ihre verwendung zur sekretorischen expression von heterologen proteinen.
PT676413E (pt) Proteina de ligacao a interferoes alfa/beta, sua preparacao e utilizacao
DE3684947D1 (de) Faktor-ix-protein.
FI970097A (fi) Proteiinit, jotka ovat peräisin nisäkkäiden maksasta ja niiden käyttö onkologiassa
DE3682358D1 (de) Expressionsvektoren zur verwendung in e. coli.
DE68912536D1 (de) Flüssiges Nahrungsmittel zur Proteinzuführung.
NO894573L (no) Rekombinante interleukin-2 hybridproteiner.
AU8957091A (en) Immunoglobulin-binding proteins and recombinant dna molecules coding therefor
DE69012109D1 (de) Dns-sequenzierung mit verwendung von chemolumineszenz.
NO892948D0 (no) Modifiserte proteiner.
DE59009060D1 (de) Überexpression von Proteinen in rekombinanten Wirtszellen.
NO875477D0 (no) Rekombinant alveolaert overflateaktivt protein.
NO912072D0 (no) Rekombinante proteiner med adipsin- og komplement-d-aktiviteter.
MX9203296A (es) Proteinas bmp-7.
GB9115814D0 (en) Immunoglobulin-binding proteins and recombinant dna molecules cloding therefor
ATE75254T1 (de) Faktor-ix-protein.